Internal Medicine, Cardiovascular Disease · Lubbock, TX
NPI
1013910546
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
4802 N Loop 289
Lubbock, TX, 79416
Phone (806) 788-0040
Groups this clinician bills Medicare through
Medicare paid, 2024
$390K
6,203 services
Medicare patients, 2024
1,786
Average age 76
Drug cost, 2024
$2.9M
22,335 prescriptions
Company payments, 2025
$17K
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by M A Sharif was code 99214 (office e&m - established), 2,663 times for 1,376 patients. In total M A Sharif billed 6,203 services in 93 codes, and Medicare paid $390K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-09-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 2,663 | 1,376 | $64.59 | $172K |
| 99232 Hospital E&M - Subsequent | Facility | 702 | 223 | $59.34 | $42K |
| 93306 Echocardiography (TTE/TEE) | Facility | 592 | 530 | $49.52 | $29K |
| 93018 Electrocardiogram | Facility | 262 | 260 | $10.10 | $2,647 |
| 78452 Myocardial Perfusion Scan | Facility | 258 | 254 | $54.16 | $14K |
| 99223 Hospital E&M - Initial | Facility | 239 | 212 | $123.39 | $29K |
| 99204 Office E&M - New | Facility | 176 | 176 | $90.89 | $16K |
| 93880 Duplex Scan - Extracranial Arteries | Facility | 111 | 103 | $27.09 | $3,007 |
| 99152 Anesthesia | Facility | 104 | 95 | $9.20 | $957 |
| 93970 Duplex Scan - Extremity Veins | Facility | 98 | 93 | $24.14 | $2,365 |
| 93971 Duplex Scan - Extremity Veins | Facility | 94 | 86 | $13.34 | $1,254 |
| 99213 Office E&M - Established | Facility | 86 | 82 | $46.59 | $4,007 |
| 92960 Cardiovascular | Facility | 72 | 49 | $79.77 | $5,744 |
| 93294 External Electrocardiographic Monitoring | Facility | 60 | 27 | $18.35 | $1,101 |
| 99214 Office E&M - Established | Office | 56 | 41 | $56.19 | $3,146 |
By year: 2022 $405K for 7,827 services; 2023 $403K for 7,421 services; 2024 $390K for 6,203 services.
Medicare prescription drug claims, 2024
In 2024, the drug M A Sharif prescribed most often to Medicare patients was Metoprolol Succinate, with 2,368 prescriptions and refills. In total M A Sharif wrote 22,335 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 2,368 | 5,694 | 682 | $36K |
| Atorvastatin Calcium Generic | 2,314 | 5,552 | 648 | $17K |
| Amlodipine Besylate Generic | 1,498 | 3,620 | 423 | $8,291 |
| Eliquis Apixaban | 1,479 | 2,467 | 303 | $1.4M |
| Rosuvastatin Calcium Generic | 1,354 | 3,248 | 397 | $14K |
| Clopidogrel Clopidogrel Bisulfate | 998 | 2,439 | 296 | $9,815 |
| Lisinopril Generic | 977 | 2,333 | 285 | $7,205 |
| Losartan Potassium Generic | 822 | 2,055 | 230 | $8,547 |
| Amiodarone Hcl Generic | 754 | 1,631 | 208 | $13K |
| Valsartan Generic | 595 | 1,266 | 172 | $12K |
| Furosemide Generic | 592 | 1,231 | 214 | $2,436 |
| Hydrochlorothiazide Generic | 534 | 1,354 | 179 | $2,349 |
| Hydralazine Hcl Generic | 481 | 912 | 125 | $4,603 |
| Simvastatin Generic | 469 | 1,131 | 120 | $3,737 |
| Carvedilol Generic | 428 | 1,028 | 125 | $3,559 |
Brand drugs: - claims; generic drugs: 19,277 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid M A Sharif $17K ($17K in general payments such as food, travel and fees) from 9 companies. The largest payer was Medtronic, Inc. with $11K.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 35 | $11K |
| Abbott Laboratories ABT | 20 | $2,877 |
| Penumbra, Inc. PEN | 9 | $2,491 |
| Biosense Webster, Inc. JNJ | 2 | $89.27 |
| Amgen Inc. AMGN | 4 | $70.07 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $65 |
| Philips North America LLC PHG | 1 | $29.55 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $24.58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17.79 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.